Clinical Trial Update: Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating whether adding clemastine fumarate to dexamethasone improves effectiveness and safety in allergic dermatitis compared with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Dermatitis

Drugs mentioned

• Clemastine Fumarate (clemastine fumarate)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Azidus Brasil | Conditions: Allergy, Dermatitis | Phase 3 | Status: UNKNOWN